과제정보
This study was supported by a research fund from the Chosun University Hospital 2022 (funding number: 2022-15).
참고문헌
- Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain 2015; 28: 177-84. https://doi.org/10.3344/kjp.2015.28.3.177
- Cohen EJ, Jeng BH. Herpes zoster: a brief definitive review. Cornea 2021; 40: 943-9. https://doi.org/10.1097/ICO.0000000000002754
- Marra F, Parhar K, Huang B, Vadlamudi N. Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis 2020; 7: ofaa005. https://doi.org/10.1093/ofid/ofaa005
- Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses 2022; 14: 192. https://doi.org/10.3390/v14020192
- Majewska A, Mlynarczyk-Bonikowska B. 40 Years after the registration of acyclovir: do we need new anti-herpetic drugs? Int J Mol Sci 2022; 23: 3431. https://doi.org/10.3390/ijms23073431
- Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S. The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study. Clinicoecon Outcomes Res 2016; 8: 207-14.
- De Clercq E. FV-100 for the treatment of varicellavirus (VZV) infections: quo vadis? Viruses 2022; 14: 770. https://doi.org/10.3390/v14040770
- Andrei G, Snoeck R. Advances and perspectives in the management of varicella-zoster virus infections. Molecules 2021; 26: 1132. https://doi.org/10.3390/molecules26041132
- Tyring SK, Plunkett S, Scribner AR, Broker RE, Herrod JN, Handke LT, et al. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, doubleblind, active-controlled trial. J Med Virol 2012; 84:1224-32. https://doi.org/10.1002/jmv.23329
- De SK, Hart JC, Breuer J. Herpes simplex virus and varicella zoster virus: recent advances in therapy. Curr Opin Infect Dis 2015; 28: 589-95. https://doi.org/10.1097/qco.0000000000000211
- Zhu J, Luo G, He Q, Yao M. Evaluation of the efficacy of unipolar and bipolar spinal dorsal root ganglion radiofrequency thermocoagulation in the treatment of postherpetic neuralgia. Korean J Pain 2022; 35:114-23. https://doi.org/10.3344/kjp.2022.35.1.114
- Singh G, Song S, Choi E, Lee PB, Nahm FS. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia. Korean J Pain 2020; 33: 201-7. https://doi.org/10.3344/kjp.2020.33.3.201
- Kim SY, Kim DG, Park YM, Jeon YH. Psoas compartment block for treatment of motor weakness and pain following herpes zoster. Korean J Pain 2017; 30:62-5. https://doi.org/10.3344/kjp.2017.30.1.62
- Poole CL, James SH. Antiviral therapies for herpesviruses: current agents and new directions. Clin Ther 2018; 40: 1282-98. https://doi.org/10.1016/j.clinthera.2018.07.006
- Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis 2016; 35: 723-34. https://doi.org/10.1007/s10096-016-2605-0
- Yaldiz M, Solak B, Kara RO, Cosansu N, Erdem MT. Comparison of famciclovir, valaciclovir, and brivudine treatments in adult immunocompetent patients with herpes zoster. Am J Ther 2018; 25: e626-34. https://doi.org/10.1097/MJT.0000000000000436
- Piret J, Boivin G. Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management. Curr Opin Infect Dis 2016;29: 654-62. https://doi.org/10.1097/QCO.0000000000000288
- Muhaj FF, George SJ, Nguyen CD, Tyring SK. Antimicrobials and resistance part II: antifungals, antivirals, and antiparasitics. J Am Acad Dermatol 2022;86: 1207-26. https://doi.org/10.1016/j.jaad.2021.11.065
- Shiraki K, Yasumoto S, Toyama N, Fukuda H. Amenamevir, a helicase-primase inhibitor, for the optimal treatment of herpes zoster. Viruses 2021; 13:1547. https://doi.org/10.3390/v13081547
- Pott Junior H, de Oliveira MFB, Gambero S, Amazonas RB. Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults. Int J Infect Dis 2018; 72: 11-5. https://doi.org/10.1016/j.ijid.2018.04.4324
- Whitley RJ, Volpi A, McKendrick M, Wijck A, Oaklander AL. Management of herpes zoster and postherpetic neuralgia now and in the future. J Clin Virol 2010; 48 Suppl 1: S20-8. https://doi.org/10.1016/S1386-6532(10)70005-6
- Yeh CH, Chang KS, Huang SS, Tsay SL, Tsai JM, Wang YJ. Comparing prodrugs with acyclovir for treating postherpetic neuralgia among herpes zoster patients: a systematic review and meta-analysis. Healthcare (Basel) 2022; 10: 1181. https://doi.org/10.3390/healthcare10071181
- Ono F, Yasumoto S, Furumura M, Hamada T, Ishii N, Gyotoku T, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J Dermatol 2012; 39: 902-8. https://doi.org/10.1111/j.1346-8138.2012.01584.x
- Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database Syst Rev 2016; 11: CD011503. https://doi.org/10.1002/14651858.CD011503.pub2
- Kawashima M, Nemoto O, Honda M, Watanabe D, Nakayama J, Imafuku S, et al. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: a randomized, double-blind, valaciclovircontrolled phase 3 study. J Dermatol 2017; 44: 1219-27. https://doi.org/10.1111/1346-8138.13948
- Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (S2k) guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment. J Eur Acad Dermatol Venereol 2017; 31: 20-9. https://doi.org/10.1111/jdv.13957
- Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 2000; 61: 2437-44, 2447-8.
- Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician 2017; 96: 656-63.
- John AR, Canaday DH. Herpes zoster in the older adult. Infect Dis Clin North Am 2017; 31: 811-26. https://doi.org/10.1016/j.idc.2017.07.016
- Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014; (2): CD006866.
- Kim J, Kim MK, Choi GJ, Shin HY, Kim BG, Kang H. Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean J Pain 2021; 34: 509-33. https://doi.org/10.3344/kjp.2021.34.4.509
- Tyring SK, Lee P, Hill GT Jr, Silverfield JC, Moore AY, Matkovits T, et al. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: a randomized-controlled trial. J Med Virol 2017; 89:1255-64. https://doi.org/10.1002/jmv.24750